{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T07:55:24Z","timestamp":1722153324223},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.ejpb.2012.05.019","type":"journal-article","created":{"date-parts":[[2012,6,7]],"date-time":"2012-06-07T22:01:48Z","timestamp":1339106508000},"page":"475-484","source":"Crossref","is-referenced-by-count":11,"title":["Biophysical characterisation of thermal-induced precipitates of recombinant anthrax protective antigen: Evidence for kinetically trapped unfolding domains in solid-state"],"prefix":"10.1016","volume":"82","author":[{"given":"Ashok","family":"Ganesan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan","family":"Watkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry D.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2012.05.019_b0005","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nrd1695","article-title":"Protein drug stability: a formulation challenge","volume":"4","author":"Frokjaer","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejpb.2012.05.019_b0010","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1002\/jps.21566","article-title":"Protein aggregation: pathways, induction factors and analysis","volume":"98","author":"Mahler","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2012.05.019_b0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/ndt\/gfh1092","article-title":"Factors influencing the immunogenicity of therapeutic proteins","volume":"6","author":"Schellekens","year":"2005","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ejpb.2012.05.019_b0020","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1042\/BA20030183","article-title":"Analytical techniques for the evaluation of liquid protein therapeutics","volume":"40","author":"Tatford","year":"2004","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.ejpb.2012.05.019_b0025","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ejpb.2011.03.001","article-title":"Addressing new analytical challenges in protein formulation development","volume":"78","author":"Mach","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2012.05.019_b0030","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1007\/s11095-010-0297-1","article-title":"Strategies for the assessment of protein aggregates in pharmaceutical biotech product development","volume":"28","author":"den Engelsman","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2012.05.019_b0035","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejpb.2011.01.012","article-title":"Comparison of analytical methods to detect instability of etanercept during thermal stress testing","volume":"78","author":"Maarschalkerweerd","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2012.05.019_b0040","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1002\/jps.20423","article-title":"Biophysical characterization of insoluble aggregates of a multi-domain protein: an insight into the role of the various domains","volume":"94","author":"Souillac","year":"2005","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2012.05.019_b0045","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1002\/jps.21825","article-title":"Mechanisms of protein stabilization in the solid state","volume":"98","author":"Chang","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2012.05.019_b0050","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1002\/jps.20895","article-title":"Raman spectroscopy of protein pharmaceuticals","volume":"96","author":"Wen","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2012.05.019_b0055","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s11095-007-9516-9","article-title":"Extrinsic fluorescent dyes as tools for protein characterization","volume":"25","author":"Hawe","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2012.05.019_b0060","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.bbapap.2006.03.016","article-title":"Circular dichroism studies of subtilisin Carlsberg immobilised on micron sized silica particles","volume":"1764","author":"Ganesan","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejpb.2012.05.019_b0065","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/cphc.200800759","article-title":"Optical spectroscopic methods for probing the conformational stability of immobilised enzymes","volume":"10","author":"Ganesan","year":"2009","journal-title":"Chemphyschem"},{"key":"10.1016\/j.ejpb.2012.05.019_b0070","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/385833a0","article-title":"Crystal structure of the anthrax toxin protective antigen","volume":"385","author":"Petosa","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.ejpb.2012.05.019_b0075","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.mam.2009.06.003","article-title":"Membrane translocation by anthrax toxin","volume":"30","author":"Collier","year":"2009","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.ejpb.2012.05.019_b0080","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.addr.2005.01.028","article-title":"Molecular basis for improved anthrax vaccines","volume":"57","author":"Brey","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2012.05.019_b0085","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.bbrc.2004.08.020","article-title":"Thermal inactivation of protective antigen of Bacillus anthracis and its prevention by polyol osmolytes","volume":"322","author":"Singh","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejpb.2012.05.019_b0090","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/jps.20484","article-title":"Anthrax vaccine powder formulations for nasal mucosal delivery","volume":"95","author":"Jiang","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2012.05.019_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abb.2007.04.030","article-title":"Unfolding transitions of Bacillus anthracis protective antigen","volume":"465","author":"Chalton","year":"2007","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejpb.2012.05.019_b0100","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/nbt1012","article-title":"Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins","volume":"22","author":"Fernandez-Escamilla","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejpb.2012.05.019_b0105","doi-asserted-by":"crossref","first-page":"5978","DOI":"10.1128\/IAI.73.9.5978-5987.2005","article-title":"Immunogenicity of recombinant protective antigen and efficacy against aerosol challenge with anthrax","volume":"73","author":"Williamson","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ejpb.2012.05.019_b0110","first-page":"111","article-title":"Prevention of rhodanese aggregation by the chaperonin GroEL","volume":"vol. 140","author":"Weber","year":"2000"},{"key":"10.1016\/j.ejpb.2012.05.019_b0115","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ejpb.2004.12.004","article-title":"Induction and analysis of aggregates in a liquid IgG1-antibody formation","volume":"59","author":"Mahler","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2012.05.019_b0120","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jsb.2004.08.002","article-title":"The binding of thioflavin-T to amyloid fibrils: localisation and implications","volume":"149","author":"Krebs","year":"2005","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.ejpb.2012.05.019_b0125","series-title":"Circular Dichroism and the Conformational Analysis of Biomolecules","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/978-1-4757-2508-7_3","article-title":"Determination of protein secondary structure","author":"Venyaminov","year":"1996"},{"key":"10.1016\/j.ejpb.2012.05.019_b0130","doi-asserted-by":"crossref","first-page":"10022","DOI":"10.1021\/bi00199a028","article-title":"Poly(pro)II helices in globular proteins: identification and circular dichroic analysis","volume":"33","author":"Sreerama","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejpb.2012.05.019_b0135","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1021\/cr040433a","article-title":"Conformation of the backbone in unfolded proteins","volume":"106","author":"Shi","year":"2006","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejpb.2012.05.019_b0140","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bbapap.2005.06.005","article-title":"How to study proteins by circular dichroism","volume":"1751","author":"Kelly","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejpb.2012.05.019_b0145","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1021\/cr0404390","article-title":"Probing protein folding and conformational transitions with fluorescence","volume":"106","author":"Royer","year":"2006","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejpb.2012.05.019_b0150","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1007\/s11095-010-0143-5","article-title":"Potential aggregation-prone regions in complementarity-determining regions of antibodies and their contribution towards antigen recognition: a computational analysis","volume":"27","author":"Wang","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2012.05.019_b0155","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nchembio.546","article-title":"Gain of function of mutant p53 by coaggregation with multiple tumor suppressors","volume":"7","author":"Xu","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejpb.2012.05.019_b0160","doi-asserted-by":"crossref","first-page":"8141","DOI":"10.1021\/ja016229b","article-title":"Preparation and characterization of purified amyloid fibrils","volume":"123","author":"Zurdo","year":"2001","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejpb.2012.05.019_b0165","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1529\/biophysj.106.094342","article-title":"Protein particulates: another generic form of protein aggregation?","volume":"92","author":"Krebs","year":"2007","journal-title":"Biophys. J."},{"key":"10.1016\/j.ejpb.2012.05.019_b0170","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1006\/jmbi.2000.3981","article-title":"Is polyproline II helix the killer conformation? A Raman optical activity study of the amyloidogenic prefibrillar intermediate of human lysozyme","volume":"301","author":"Blanch","year":"2000","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejpb.2012.05.019_b0175","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1074\/jbc.M605984200","article-title":"A role for protein misfolding in immunogenicity of biopharmaceuticals","volume":"282","author":"Maas","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejpb.2012.05.019_b0180","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/35065514","article-title":"Amyloid fibrils from muscle myoglobin","volume":"410","author":"Fandrich","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ejpb.2012.05.019_b0185","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nchembio.131","article-title":"Amyloid formation by globular proteins under native conditions","volume":"5","author":"Chiti","year":"2009","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejpb.2012.05.019_b0190","doi-asserted-by":"crossref","first-page":"24452","DOI":"10.1074\/jbc.M400004200","article-title":"Annular oligomeric amyloid intermediates observed by in situ atomic force microscopy","volume":"273","author":"Zhu","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejpb.2012.05.019_b0195","doi-asserted-by":"crossref","first-page":"25118","DOI":"10.1074\/jbc.M110.160457","article-title":"Classification and characterization of therapeutic antibody aggregates","volume":"286","author":"Joubert","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejpb.2012.05.019_b0200","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/srep00040","article-title":"Stability of domain structures in multi-domain proteins","volume":"1","author":"Bhaskara","year":"2011","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejpb.2012.05.019_b0205","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0014-5793(03)01226-2","article-title":"Conformational fluctuations in anthrax protective antigen: a possible role of calcium in the folding pathway of the protein","volume":"554","author":"Gupta","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejpb.2012.05.019_b0210","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0006-291X(02)02771-7","article-title":"Exchange characteristics of calcium ions bound to anthrax protective antigen","volume":"300","author":"Gao-Sheridan","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejpb.2012.05.019_b0215","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1128\/JB.183.6.2111-2116.2001","article-title":"Involvement of domain 3 in oligomerization by the protective antigen moiety of anthrax toxin","volume":"183","author":"Mogridge","year":"2003","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.ejpb.2012.05.019_b0220","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nature02763","article-title":"Crystal structure of a complex between anthrax toxin and its host cell receptor","volume":"430","author":"Santelli","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.ejpb.2012.05.019_b0225","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1002\/pro.238","article-title":"Domain 4 of the anthrax protective antigen maintains structure and binding to the host receptor CMG2 at low pH","volume":"18","author":"Williams","year":"2009","journal-title":"Protein Sci."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641112001865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641112001865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,7]],"date-time":"2019-03-07T03:35:18Z","timestamp":1551929718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641112001865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0939641112001865"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2012.05.019","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}